메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
ObjectiveTo investigate the patterns of estradiol-oocyte ratio (EOR) and estradiol-mature oocyte ratio (EMOR) in patientswith breast cancer undergoing controlled ovarian stimulation (COS) using letrozole and gonadotropins for fertilitypreservation. MethodsThis retrospective study included 32 breast cancer patients underwent COS for fertility preservation and no patientshad previously undergone gonadotoxic treatments. Basal characteristics and in vitro fertilization (IVF) outcomes werecompared according to the age of women (age <35 vs. age ≥35) and the starting phase of ovarian stimulation (earlyfollicular phase vs. late follicular phase vs. luteal phase). ResultsPatients who were administered with a letrozole-combined regimen, the peak serum estradiol (E2) was maintainedat a low level (386.3±346.9 pg/mL). EOR was 52.4±78.8 pg/mL, and EMOR was 71.0±41.2 pg/mL. When the 2 groupswere compared according to the age of women (age <35 vs. age ≥35), EOR was 34.5 (22.2–46.5) pg/mL and 40.7(19.3–65.3) pg/mL, respectively; EMOR was 79.8 (40.8–90.6) pg/mL and 68.8 (44.5–85.9) pg/mL, respectively. There wasno significant difference in the IVF outcomes. When the 2 groups were compared according to the starting phase ofovarian stimulation, there were no significant differences in IVF outcomes, EOR and EMOR among the groups. ConclusionMeasuring the peak E2 concentration in breast cancer patients undergoing IVF for fertility preservation with a cotreatmentof letrozole allows for the prediction of the numbers of oocytes and mature oocytes.

목차

등록된 정보가 없습니다.

참고문헌 (6)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0